NCT06111430 Long-term Neurovascular Complications After Radiation Therapy in Head and Neck Cancer
| NCT ID | NCT06111430 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Chang Gung Memorial Hospital |
| Condition | Radiation Treatment |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2022-04-11 |
| Primary Completion | 2023-04-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2022-04-11 with a primary completion date of 2023-04-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Head and neck cancer is a group of cancers develop from the soft tissues, salivary gland, mucosa of the upper respiratory or digestive system covering the oral and nasal cavity. Radiotherapy is usually the standard treatment of Head and neck cancers. In the present study, investigators aim to study the prevalence of cervical-cranial vascular complications during the early stages in these Head and neck cancer patients receiving Radiotherapy. Investigators will also compare the results between Nasopharyngeal cancer and other Head and neck cancerpatients receiving Radiotherapy.
Eligibility Criteria
Population: Prospective cohort Inclusion Criteria: 1. Age ≥20 years. 2. Head and neck cancer patient . 3. Had ever received radiation therapy (RT) ≦ 72 months before inclusion in the registry. 4. Had ≥ 1 brain images and cervical-cranial vascular studies between the end of RT and d date of enrolment. Exclusion Criteria: 1. Age \<20 years. 2. Patients not willing to sign the informed consent. Population: Retrospective validation cohort Inclusion Criteria: 1. Age ≥20 years. 2. Head and neck cancer patient. 3. Had ever received radiation therapy (RT) \> 120 months before the adoption date of IRB at the participant site. 4. Had ≥ 2 brain images and cervical-cranial vascular studies between the end of RT and 6\~10 years after RT, one within 5 years after RT, the other after 5 years after RT. Exclusion Criteria: 1.Age \<20 years.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06111430 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 100 Years, studying Radiation Treatment. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06111430 currently recruiting?
Yes, NCT06111430 is actively recruiting participants. Contact the research team at ivanliu001@cgmh.org.tw for enrollment information.
Where is the NCT06111430 trial being conducted?
This trial is being conducted at Taipei, Taiwan.
Who is sponsoring the NCT06111430 clinical trial?
NCT06111430 is sponsored by Chang Gung Memorial Hospital. The trial plans to enroll 800 participants.